This Is MS Multiple Sclerosis Knowledge & Support Community

Spinal Cord alteration in multiple sclerosis could lead to new therapeutic target

A recent study led by researchers at the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, revealed a promising new method for MS treatment. The study was published in the journal Annals of Clinical and Translational Neurology and is entitled “Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis...........” - Read More - http://www.ms-uk.org/nervecells

I have seen drugs come and go on the basis of remyelination effects in mice. Since we have evidence of important differences in the lifetimes of and factors in the growth of oligodendrocytes in mice vs humans, should we not ask for some better evidence than EAE before committing support for human trials?